Anti-Emetic Drugs Market By Emerging Trends, Business Strategies, Technologies, Revenue and Competitive Landscape
Data Bridge Market Research analyses that the global anti-emetic drugs market which was USD 7,543.13 million in 2022, is expected to reach USD 12,840.23 million by 2030, and is expected to undergo a CAGR of 6.06% during the forecast period of 2023 to 2030. “D2 Receptors” dominates the site of action segment of the global anti-emetic drugs market due to rising demand of anti-emetic drugs. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market research analysis data included in this report lend a hand to businesses for planning of strategies related to investment, revenue generation, production, product launches, costing, inventory, purchasing and marketing. What's more, anti-emetic drugs market report presents the data and information for actionable, most recent and real-time market insights which makes it easier to even take critical business decisions.
Download Copy of this Report to understand structure of the complete @ Market Definition:
Anti-emetics are medications that help the body block certain neurotransmitters. Motion sickness, vestibular disorder, pregnancy, panic, medications, migraine, and gastrointestinal pathology are all typical causes of vomiting and nausea, which can be quite distressing. Postoperative nausea and vomiting are one of the most common causes of patient unhappiness after anesthesia (PONV). For the treatment of nausea and vomiting, anti-emetics such as dopamine antagonists, anticholinergics, antihistamines, serotonin antagonists, and others are available.
Market Overview:
Antiemetic drugs are medications that assist prevent nausea, dizziness, and vomiting. Antiemetic drugs are used to treat a variety of disorders, including vertigo and motion sickness. Anti-emetics have a high volume market because most drugs have reached the end of their patent protection period. Despite scientific efforts to improve the efficacy of target site specificity, the anti-emetics business is mostly focused on generic medication development. The application of anti-emetics for oncological therapy is also being investigated. Antiemetic medications are required throughout chemotherapy-induced vomiting and the early stages of pregnancy. Antiemetic medications are also used to treat toxins, food poisoning, and the side effects of other drugs that cause nausea and vomiting.
Market Scope and Size:
The global anti-emetic drugs market is segmented on the basis of site of action, indication, drug class, type, route of administration, end-users and distribution channel.
Site of Action
• D2 Receptors
• 5ht-3 Receptors
• Mi Receptors
• Hi Receptors
Indication
• Chemotherapy
• Motion Sickness
• Gastroenteritis
• Dizziness
• Pregnancy
• Food Poisoning
• Others
Drug Class
• Prokinetics
• Serotonin Antagonists
• Antimuscarinics
• Antihistaminic
• Neurokinin Antagonists
• Others
Country Level Analysis:
The countries covered in the global anti-emetic drugs market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Key Players:
Some of the major players operating in the global anti-emetic drugs market are:
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Ireland)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Merck & Co., Inc. (U.S.)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• Dr. Reddy's Laboratories Ltd. (India)
• Fresenius Kabi AG (Germany)
Download Sample PDF Copy of this Report to understand structure of the complete report @ TABLE OF CONTENTS:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Pipeline Analysis
Part 06: Market Sizing
Continue………
Browse Trending Reports:
• Global Fibroblast Activation Protein Inhibitors Market
• Global Glomerular Disease Therapeutics Market
• Global Pilar CystTreatment Market
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and n
Data Bridge Market Research analyses that the global anti-emetic drugs market which was USD 7,543.13 million in 2022, is expected to reach USD 12,840.23 million by 2030, and is expected to undergo a CAGR of 6.06% during the forecast period of 2023 to 2030. “D2 Receptors” dominates the site of action segment of the global anti-emetic drugs market due to rising demand of anti-emetic drugs. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market research analysis data included in this report lend a hand to businesses for planning of strategies related to investment, revenue generation, production, product launches, costing, inventory, purchasing and marketing. What's more, anti-emetic drugs market report presents the data and information for actionable, most recent and real-time market insights which makes it easier to even take critical business decisions.
Download Copy of this Report to understand structure of the complete @ Market Definition:
Anti-emetics are medications that help the body block certain neurotransmitters. Motion sickness, vestibular disorder, pregnancy, panic, medications, migraine, and gastrointestinal pathology are all typical causes of vomiting and nausea, which can be quite distressing. Postoperative nausea and vomiting are one of the most common causes of patient unhappiness after anesthesia (PONV). For the treatment of nausea and vomiting, anti-emetics such as dopamine antagonists, anticholinergics, antihistamines, serotonin antagonists, and others are available.
Market Overview:
Antiemetic drugs are medications that assist prevent nausea, dizziness, and vomiting. Antiemetic drugs are used to treat a variety of disorders, including vertigo and motion sickness. Anti-emetics have a high volume market because most drugs have reached the end of their patent protection period. Despite scientific efforts to improve the efficacy of target site specificity, the anti-emetics business is mostly focused on generic medication development. The application of anti-emetics for oncological therapy is also being investigated. Antiemetic medications are required throughout chemotherapy-induced vomiting and the early stages of pregnancy. Antiemetic medications are also used to treat toxins, food poisoning, and the side effects of other drugs that cause nausea and vomiting.
Market Scope and Size:
The global anti-emetic drugs market is segmented on the basis of site of action, indication, drug class, type, route of administration, end-users and distribution channel.
Site of Action
• D2 Receptors
• 5ht-3 Receptors
• Mi Receptors
• Hi Receptors
Indication
• Chemotherapy
• Motion Sickness
• Gastroenteritis
• Dizziness
• Pregnancy
• Food Poisoning
• Others
Drug Class
• Prokinetics
• Serotonin Antagonists
• Antimuscarinics
• Antihistaminic
• Neurokinin Antagonists
• Others
Country Level Analysis:
The countries covered in the global anti-emetic drugs market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Key Players:
Some of the major players operating in the global anti-emetic drugs market are:
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Ireland)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Merck & Co., Inc. (U.S.)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• Dr. Reddy's Laboratories Ltd. (India)
• Fresenius Kabi AG (Germany)
Download Sample PDF Copy of this Report to understand structure of the complete report @ TABLE OF CONTENTS:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Pipeline Analysis
Part 06: Market Sizing
Continue………
Browse Trending Reports:
• Global Fibroblast Activation Protein Inhibitors Market
• Global Glomerular Disease Therapeutics Market
• Global Pilar CystTreatment Market
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and n
11 months ago
